isoborneol has been researched along with edaravone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, C; Li, X; Li, Y; Wang, L; Xue, M | 1 |
| Gao, LY; Hua, Y; Liao, GY; Luo, CX; Sun, WX; Tang, Y; Wu, HY; Yang, SB; Zhang, ZP; Zhou, QG; Zhu, DY | 1 |
| Feng, L; Liu, L; Shen, Y; Sun, Y; Wu, X; Xu, F; Xu, Q; Zhang, X | 1 |
| Chen, H; Chen, X; Dong, A; Gao, Z; Geng, D; Ji, Y; Li, S; Liu, B; Lu, Z; Meng, X; Mu, H; Wang, A; Wang, Y; Xu, A; Xu, J; Yalkun, G; Zhao, X; Zheng, H; Zhu, R | 1 |
| An, W; Chen, R; Hua, Y; Kou, X; Ren, J; Su, H; Yang, W; Zhang, Z; Zhao, Z; Zhou, L; Zou, J | 1 |
| Gao, Y; Li, H; Li, Z; Liang, C; Liu, Z; Peng, P; Qi, D; Yang, Z; Zhang, Q | 1 |
1 trial(s) available for isoborneol and edaravone
| Article | Year |
|---|---|
Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke: A Phase III, Randomized, Double-Blind, Comparative Trial.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents; Antioxidants; Camphanes; Double-Blind Method; Edaravone; Female; Humans; Ischemic Stroke; Male; Middle Aged; Neuroprotective Agents; Treatment Outcome | 2021 |
5 other study(ies) available for isoborneol and edaravone
| Article | Year |
|---|---|
Pharmacokinetic interaction between puerarin and edaravone, and effect of borneol on the brain distribution kinetics of puerarin in rats.
Topics: Animals; Antioxidants; Antipyrine; Brain; Camphanes; Chromatography, High Pressure Liquid; Drug Interactions; Drugs, Chinese Herbal; Edaravone; Free Radical Scavengers; Half-Life; Isoflavones; Limit of Detection; Male; Metabolic Clearance Rate; Microdialysis; Random Allocation; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2010 |
The synergetic effect of edaravone and borneol in the rat model of ischemic stroke.
Topics: Animals; Anti-Inflammatory Agents; Antipyrine; Brain; Brain Ischemia; Camphanes; Cell Survival; Cells, Cultured; Coculture Techniques; Cyclooxygenase 2; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Edaravone; Free Radical Scavengers; Interleukin-1beta; Maze Learning; Neuroglia; Neurons; Rats, Sprague-Dawley; Stroke; Tumor Necrosis Factor-alpha | 2014 |
(+)-Borneol improves the efficacy of edaravone against DSS-induced colitis by promoting M2 macrophages polarization via JAK2-STAT3 signaling pathway.
Topics: Animals; Antipyrine; Camphanes; Cell Differentiation; Cells, Cultured; Colitis; Colon; Cytokines; Dextran Sulfate; Drug Combinations; Edaravone; Female; Inflammation; Janus Kinase 2; Macrophages; Mice; Mice, Inbred C57BL; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Th2 Cells | 2017 |
Y-2 reduces oxidative stress and inflammation and improves neurological function of collagenase-induced intracerebral hemorrhage rats.
Topics: Animals; Brain Edema; Camphanes; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Drug Combinations; Edaravone; Humans; Male; Neuroprotective Agents; Rats | 2021 |
Herb-drug interaction of Xingnaojing injection and Edaravone via pharmacokinetics, mixed inhibition of UGTs, and molecular docking.
Topics: Animals; Chromatography, Liquid; Edaravone; Glucuronosyltransferase; Herb-Drug Interactions; Ischemic Stroke; Molecular Docking Simulation; Rats; Tandem Mass Spectrometry | 2023 |